Table 1 Analysis of EBV infection prevalence among different studied groups.
From: The prevalence of CMV and EBV among the patients with the colorectal cancer; a molecular approach
| Â | Variable | Frequency | p-value |
|---|---|---|---|
Health condition | Healthy | 65/80 (81.25%) | Â |
| Â | Cancer patients | 70/80 (87.5%) | P=0.384 |
Sex | Male | 87/100 (87%) | Â |
| Â | Female | 48/60 (80%) | P=0.265 |
Location | Urban | 80/93 (86%) | Â |
| Â | Rural | 55/67 (82.1%) | P-0.516 |